No black box warning on record for Desflurane

As of the latest FDA labeling reviewed, Desflurane (DESFLURANE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Desflurane medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Malignant Hyperthermia: Malignant hyperthermia may occur, especially in individuals with known or suspected susceptibility based on genetic factors or family history. Discontinue triggering agents, administer intravenous dantrolene sodium, and apply supportive therapies. ( 5.1 ) Perioperative Hyperkalemia: Perioperative hyperkalemia may occur. Patients with latent or ove
5.4 QTc Prolongation QTc prolongation, associated with torsade de pointes, has been reported [See Adverse Reactions ( 6.2 )]. Carefully monitor cardiac rhythm when administering desflurane to susceptible patients (e.g., patients with congenital Long QT Syndrome or patients taking drugs that can prolong the QT interval).

No black box warning on record for Desflurane

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Malignant Hyperthermia: Malignant hyperthermia may occur, especially in individuals with known or suspected susceptibility based on genetic factors or family history. Discontinue triggering agents, administer intravenous dantrolene sodium, and apply supportive therapies. ( 5.1 ) Perioperative Hyperkalemia: Perioperative hyperkalemia may occur. Patients with latent or ove
5.4 QTc Prolongation QTc prolongation, associated with torsade de pointes, has been reported [See Adverse Reactions ( 6.2 )]. Carefully monitor cardiac rhythm when administering desflurane to susceptible patients (e.g., patients with congenital Long QT Syndrome or patients taking drugs that can prolong the QT interval).

Desflurane Black Box Warning

No black box warning on record for Desflurane

Other warnings & precautions

Desflurane Black Box Warning

No black box warning on record for Desflurane

Other warnings & precautions